Resilience in the suprachiasmatic nucleus: Implications for aging and Alzheimer's disease

Fabian Xosé Fernandez, Sevag Kaladchibachi, David C. Negelspach

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Many believe that the circadian impairments associated with aging and Alzheimer's disease are, simply enough, a byproduct of tissue degeneration within the central pacemaker, the suprachiasmatic nucleus (SCN). However, the findings that have accumulated to date examining the SCNs obtained postmortem from the brains of older individuals, or those diagnosed with Alzheimer's disease upon autopsy, suggest only limited atrophy. We review this literature as well as a complementary one concerning fetal-donor SCN transplant, which established that many circadian timekeeping functions can be maintained with rudimentary (structurally limited) representations of the SCN. Together, these corpora of data suggest that the SCN is a resilient brain region that cannot be directly (or solely) implicated in the behavioral manifestations of circadian disorganization often witnessed during aging as well as early and late progression of Alzheimer's disease. We complete our review by suggesting future directions of research that may bridge this conceptual divide and briefly discuss the implications of it for improving health outcomes in later adulthood.

Original languageEnglish (US)
Article number111258
JournalExperimental Gerontology
StatePublished - May 2021


  • Aging
  • Alzheimer's disease
  • Circadian
  • Neurodegeneration
  • Phototherapy
  • Suprachiasmatic nucleus

ASJC Scopus subject areas

  • Biochemistry
  • Aging
  • Molecular Biology
  • Genetics
  • Endocrinology
  • Cell Biology


Dive into the research topics of 'Resilience in the suprachiasmatic nucleus: Implications for aging and Alzheimer's disease'. Together they form a unique fingerprint.

Cite this